Sexual side effects and how often they happen
Sexual side effects are the most common drug-related problems with finasteride, and in the trials they affected a small minority of men. The Propecia label pools three 12-month studies in which 945 men took finasteride 1 mg and 934 took a placebo (an inactive tablet). The table shows the share of men in each group with a side effect the investigators judged to be drug related.
| Side effect in year 1 | Finasteride 1 mg | Placebo |
|---|---|---|
| Decreased libido (sex drive) | 1.8% | 1.3% |
| Erectile dysfunction | 1.3% | 0.7% |
| Ejaculation disorder | 1.2% | 0.7% |
| Decreased volume of ejaculate | 0.8% | 0.4% |
| Stopped the drug because of a sexual side effect | 1.2% | 0.9% |
According to the label, these effects went away in men who stopped the drug and in most men who kept taking it, and the rate of each one fell to 0.3% or less by the fifth year of treatment. The key trials page covers how these studies were run.
Effects that continue after stopping
Some men have reported sexual symptoms that lasted after they stopped finasteride, and the label has carried that information since 2011 and 2012. In April 2012 the FDA expanded the Propecia label to include libido disorders, ejaculation disorders and orgasm disorders that continued after discontinuation. Erectile dysfunction that continued after stopping had been added in 2011.
The FDA based the change on 421 reports of sexual dysfunction sent to its adverse event database between 1998 and 2011. In 59 of them the problem lasted at least three months after Propecia was stopped. The agency said a clear causal link had not been established, and reports of this kind cannot show how often something happens. Patients and some researchers call this cluster of lasting symptoms post-finasteride syndrome. One interview study described 71 such men, but it recruited only men who already had the problem, so it cannot estimate the risk for a new user.
The label change in 2012 was based on voluntary reports, not on a trial. It tells you persistent symptoms have been reported. It does not tell you how likely they are.
Mood changes and breast changes
Depression, suicidal thoughts and breast changes all appear in the label as reports made after approval. The current Propecia label lists depression, suicidal ideation and behavior, breast tenderness and enlargement (gynecomastia), and male breast cancer under postmarketing experience. In the Propecia trials themselves, breast tenderness and enlargement were no more common with finasteride than with placebo. A new low mood or thoughts of self-harm after starting the drug is a reason to contact the prescriber right away. The long-term safety page goes through the evidence in more detail.
PSA tests and the pregnancy warning
Finasteride lowers PSA, a blood marker used in prostate cancer screening, and it must be kept away from pregnancy. In men aged 18 to 41 in the Propecia studies, average PSA fell from 0.7 to 0.5 ng/mL at 12 months, and the 5 mg dose lowers PSA by about half. Anyone having a PSA test should say they take finasteride so the result is read correctly. See interactions and lab tests.
Finasteride is contraindicated in pregnancy because blocking DHT can cause abnormal development of the genitals of a male fetus. Women who are or may be pregnant should not handle crushed or broken tablets. Whole tablets are coated, which prevents contact with the drug during normal handling. More on this is on the finasteride and women page.
Common questions
How common is erectile dysfunction on finasteride?
In the first year of the Propecia trials it was reported as drug related by 1.3% of men on finasteride 1 mg and 0.7% of men on placebo.
Do finasteride side effects go away?
The label states that sexual side effects resolved in men who stopped the drug and in most who continued. It also lists reports, received after approval, of sexual symptoms that continued after stopping.
Are side effects more common at 5 mg?
The trials are not directly comparable, but rates were higher in the older men who took 5 mg for an enlarged prostate. In year one of the PLESS trial, impotence was reported by 8.1% on finasteride and 3.7% on placebo.
Does topical finasteride avoid side effects?
Not entirely. The FDA says finasteride applied to the scalp is expected to reach the bloodstream, and it has received side effect reports for compounded topical products. See the topical finasteride page.
Sources
- Organon. Propecia (finasteride) tablets 1 mg, full prescribing information and patient information. DailyMed, National Library of Medicine. DailyMed: Propecia label
- Organon. Proscar (finasteride) tablets 5 mg, full prescribing information. DailyMed, National Library of Medicine. DailyMed: Proscar label
- US Food and Drug Administration. Questions and Answers: Finasteride Label Changes, April 2012 (archived copy). FDA questions and answers
- Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. Journal of Sexual Medicine, 2011. PubMed 21418145
- US Food and Drug Administration. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products, 2025. FDA alert